1st drug for rare rapid-aging disease extends kids' lives

This photo provided by Eiger BioPharmaceuticals shows the pharmaceutical drug Zokinvy. The first treatment has been approved for progeria, an extremely rare genetic disorder that causes rapid aging, stunts growth and typically kills children in their early teens. The U.S. Food and Drug Administration on Friday, Nov. 20, 2020 approved. Zokinvy